Bicocca Open Archive

Logo unimib boa
CIARDULLO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.846
EU - Europa 1.834
AS - Asia 885
AF - Africa 18
SA - Sud America 15
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.791
IT - Italia 561
SG - Singapore 398
DE - Germania 306
RU - Federazione Russa 264
IE - Irlanda 256
CN - Cina 219
SE - Svezia 203
HK - Hong Kong 132
GB - Regno Unito 90
CA - Canada 52
IN - India 33
VN - Vietnam 32
FI - Finlandia 29
NL - Olanda 27
TR - Turchia 17
FR - Francia 16
ID - Indonesia 16
BE - Belgio 14
UA - Ucraina 14
DK - Danimarca 13
JP - Giappone 11
AU - Australia 7
BR - Brasile 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
PL - Polonia 6
PT - Portogallo 6
RO - Romania 6
DZ - Algeria 5
EG - Egitto 5
IR - Iran 5
SA - Arabia Saudita 5
AR - Argentina 4
KR - Corea 4
MA - Marocco 4
TW - Taiwan 4
CO - Colombia 3
AT - Austria 2
CY - Cipro 2
ES - Italia 2
NG - Nigeria 2
NO - Norvegia 2
PK - Pakistan 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
JE - Jersey 1
MD - Moldavia 1
MX - Messico 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
TH - Thailandia 1
Totale 5.606
Salva come PNG Salva come JPEG
Città #
Ann Arbor 702
Singapore 360
Frankfurt am Main 253
Santa Clara 248
Dublin 247
Chandler 201
Fairfield 175
Milan 157
New York 130
Hong Kong 128
Wilmington 99
Princeton 96
Ashburn 93
Chicago 87
Woodbridge 70
Cambridge 67
Seattle 64
Houston 60
Altamura 58
London 49
Lawrence 47
Beijing 43
Shanghai 39
San Diego 36
Boardman 28
Bari 25
Dong Ket 24
Helsinki 22
Rome 22
Nanjing 16
Toronto 16
Jakarta 15
Kocaeli 15
Brussels 14
Guangzhou 13
Los Angeles 12
Monza 12
Carate Brianza 11
Dearborn 11
Andover 10
Pune 10
Capurso 9
Groningen 9
Norwalk 9
Sacramento 9
Florence 8
Hyderabad 8
Lappeenranta 7
Munich 7
Amsterdam 6
Esslingen am Neckar 6
Wenzhou 6
Bergamo 5
Brno 5
Falls Church 5
Floridia 5
Laurel 5
Naples 5
Riyadh 5
San Mateo 5
São Paulo 5
Abbadia Lariana 4
Cascina 4
Charlottesville 4
Hangzhou 4
Kilburn 4
New Delhi 4
Oujda 4
Palermo 4
Pontedera 4
Raleigh 4
Redmond 4
Segrate 4
Southwark 4
Torino 4
Washington 4
Berlin 3
Cinisello Balsamo 3
Council Bluffs 3
Ergolding 3
Fremont 3
Fukuyama 3
Giza 3
Gunzenhausen 3
Jacksonville 3
Jalandhar 3
Kardzhali 3
Leawood 3
Legnano 3
Lissone 3
Magenta 3
Messina 3
Mistretta 3
Montreal 3
Novara 3
Paris 3
Parma 3
Pisa 3
Tokyo 3
Trumbull 3
Totale 4.046
Salva come PNG Salva come JPEG
Nome #
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 342
Endocrinology and Metabolic Diseases (Including Diabetes) 169
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 169
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 164
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 161
Exploring the landscape of steatotic liver disease in the general US population 156
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 144
Lack of awareness of liver organ damage in patients with type 2 diabetes 121
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 119
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 119
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 115
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction 102
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 98
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 98
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 91
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016 90
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 90
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 90
Risk stratification tools for heart failure in the diabetes clinic 88
An unexpected bilateral mass after total thyroidectomy 86
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 85
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes 85
Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. women 85
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 83
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 82
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 82
Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease 79
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 79
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 78
Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population 74
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 71
Comment on “An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD” 71
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents 71
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 70
NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population 70
Reply [to: Use of FibroScan–AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US...] 69
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 69
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 69
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 68
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 67
Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population 66
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 64
Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study 61
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting 60
Global multi-stakeholder endorsement of the MAFLD definition 57
Non-invasive scores of liver fibrosis in morbidly obese patients 56
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes and association with micro- and macrovascular complications 55
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 53
Sex-related association of NAFLD and liver fibrosis with body fat distribution in the general US population 53
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 52
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis 52
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 51
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 50
Twenty-year trends in heart failure among U.S. adults, 1999–2018: The growing impact of obesity and diabetes 50
Control of Blood Glucose and Cardiovascular Risk Profile 48
Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study 46
Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States 44
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 43
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 43
Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD 43
Authors' reply to Zou et al 42
Advances in fibrosis biomarkers in nonalcoholic fatty liver disease 42
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 41
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 40
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 40
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 39
Authors' reply to Shang et al. 36
Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition 35
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 35
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 34
Serum neurofilament light chain levels are associated with all-cause mortality in the general US population 34
Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes 33
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment 31
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 31
Liver stiffness is associated with all-cause mortality in patients with NAFLD: A systematic review and meta-analysis 30
Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis 29
Trends in prevalence of probable fibrotic nonalcoholic steatohepatitis in the United States, 1999-2016 29
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus 26
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence 24
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 23
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 22
Silent threats: how NAFLD and hypertension team up in young adults, and the role of sex 21
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner? 20
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 11
Prevalence of Noninvasively Detected Clinically Significant Portal Hypertension Among U.S. Adults With and Without Diabetes 10
Authors' response to Guo, Wei et al. 8
Totale 5.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020181 0 0 0 0 16 17 14 22 29 34 31 18
2020/2021998 16 30 45 65 72 70 85 116 133 144 88 134
2021/2022741 117 88 99 42 25 52 28 35 50 62 44 99
2022/20231.240 146 226 123 108 92 228 40 71 87 26 58 35
2023/20241.236 89 42 84 102 112 216 166 53 91 53 34 194
2024/20251.466 215 404 309 233 305 0 0 0 0 0 0 0
Totale 5.932